MedPath

A comparison of the effects and complications of transforaminal Triamcinolone and Ketorolac in radicular low back pain.

Not Applicable
Recruiting
Conditions
chronic low back pain.
low back pain
Registration Number
IRCT201708157984N27
Lead Sponsor
Vice Chancellor for Research and Technology of Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Age 20-70 years;
Pain that has not responded to treatment for at least 6 weeks;
Evidence of Nerve root involvement as disc bulging and/or foraminal stenosis in CT/MRI;
VAS > 4;
ASA class I, II;
Patients’ Informed consent;

Exclusion criteria:

Patients with coagulopathy;
Infection in injection site as Herpetic diseases;
Anatomical and congenital spine deformity as severe scoliosis;
Surgical history instrument insertion;
Psychological severe disorders;
History of harmful reaction to local anesthetic and steroid;
Patients with motor deficit or progressive neural defect;
Cancer;
Neural foramen radiological access difficulty;
Substance abuse;
HIV;
Acute trauma;
Cauda Equina syndrome;
More than 3 level abnormalities;
Absence of radicular pain;

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ow back pain. Timepoint: Before injection,two weeks,1,3 and 6 month after intervention. Method of measurement: pain score measured with visual analogue scale in Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Oswestry Disability Index questionnaire (ODI) and straight leg raising test (SLR), complications. Timepoint: Before injection, two weeks, 1,3 and 6 moth after intervention. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath